🔎 Trials Near Me

Pradžia › Šizofrenija › Ohio

Šizofrenija klinikiniai tyrimai Ohio

18 tyrimai dėl Šizofrenija ieško dalyvių vietose Ohio.

Miestai Ohio

Oficialus tyrimo tekstas (anglų kalba)

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

  • Vanda Investigational Site, Cincinnati
  • Vanda Investigational Site, Garfield Heights
  • Vanda Investigational Site, Westlake
Renkami dalyviai4 fazė
Amžius nuo 12 iki 17 · Visoms lytims · Atnaujinta 2026-10-01 · NCT05648591

Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)

  • Westlake Brain Health, Westlake
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07101094

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

  • Local Institution - 0183, Cincinnati
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-28 · NCT07686263

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

  • University of Cincinnati Medical Center, Cincinnati
  • Charak Center for Health and Wellness, Garfield Heights
Renkami dalyviai3 fazė
Amžius nuo 5 iki 17 · Visoms lytims · Atnaujinta 2026-09-25 · NCT06229210

NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

  • Neurocrine Clinical Site, North Canton
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07105098

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

  • Neurocrine Clinical Sites, North Canton
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07114874

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

  • University of Cincinnati Cancer Institute, Cincinnati
  • Local Institution - 0148, Cincinnati
Renkami dalyviai3 fazė
Amžius nuo 5 iki 17 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07424404

A Study of Brenipatide in Adult Participants With Schizophrenia

  • Insight Clinical Trials, Independence
Renkami dalyviai2 fazė
Amžius nuo 18 iki 55 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07410507

52-week Open Label Safety-Tolerability Study

  • Neuro-Behavioral Clinical Research, Canton
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-09 · NCT07369154

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

  • University of Cincinnati Dept of Psychiatry and Behavioral Neuroscience, Cincinnati
Renkami dalyviai3 fazė
Amžius nuo 13 iki 17 · Visoms lytims · Atnaujinta 2026-09-04 · NCT07288567

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

  • Clinical Site, North Canton
  • Clinical Site, West Chester
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-01 · NCT07459647

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

  • Local Institution - 0031, Mason
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-19 · NCT07379827

REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)

  • Case Western Reserve University, Cleveland
Renkami dalyviai
Amžius nuo 18 iki 50 · Visoms lytims · Atnaujinta 2026-08-17 · NCT07006935

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

  • Alkermes Investigator Site, Cincinnati
  • Alkermes Investigator Site, West Chester
Renkami dalyviai3 fazė
Amžius nuo 10 iki 17 · Visoms lytims · Atnaujinta 2026-08-14 · NCT05303064

Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia

  • Neuro-Behavioral Clinical Research, North Canton
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-07-27 · NCT07363577

A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

  • Neuro-Behavioral Clinical Research, North Canton
Renkami dalyviai2 fazė
Amžius nuo 18 iki 55 · Visoms lytims · Atnaujinta 2026-06-23 · NCT07191483

Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis

  • Harding Hospital, Columbus
Renkami dalyviai
Amžius nuo 15 iki 35 · Visoms lytims · Atnaujinta 2026-02-25 · NCT04368039

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.